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Abstract 
Background: Discogenic pain or herniation causing neural impingement of the thoracic ver-
tebrae is less common than that in the cervical or lumbar regions. Treatment of thoracic 
discogenic pain usually involves conservative measures. If this fails, conventional fusion or 
discectomy can be considered, but these procedures carry significant risk.  
Objectives: To assess the efficacy and safety of percutaneous laser disc decompression (PLDD) 
for the treatment of thoracic disc disease.  
Methods: Ten patients with thoracic discogenic pain who were unresponsive to conservative 
intervention underwent the PLDD procedure. Thoracic pain was assessed using the Visual 
Analog Scale (VAS) scores preoperatively and at 6-month intervals with a minimum of 
18-months follow-up. Patients were diagnosed and chosen for enrollment based on abnormal 
MRI findings and positive provocative discograms. Patients with gross herniations were not 
included. 
Results: Length of follow-up ranged from 18 to 31 months (mean: 24.2 mo). Median pre-
treatment thoracic VAS score was 8.5 (range: 5-10) and median VAS score at final follow-up 
was 3.8 (range: 0-9). Postoperative improvement was significant with a 99% confidence in-
terval. Of interest, patients generally fell into two groups, those with significant pain reduction 
and those with little to no improvement. Although complications such as pneumothorax, 
discitis, or nerve damage were possible, no adverse events occurred during the procedures.  
Limitations: The study is limited by its small size and lack of a sham group. Larger controlled 
studies are warranted. 
Conclusions: With further clinical evidence, PLDD could be considered a viable option with a 
low risk of complication for the treatment of thoracic discogenic pain that does not resolve 
with conservative treatment. 
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Background and objectives 
Percutaneous laser disc decompression (PLDD) 
is a minimally invasive treatment option for vertebral 
disc herniation refractory to conservative treatment. 
PLDD was first used in 1986 and received approval 
from the U.S. Food and Drug Administration in 1991 
(1). Based on the reduced risk associated with less 
invasive procedures, PLDD has increased in popular-




performed in 2001 (2). PLDD is performed under local 
anesthesia via a laser fiber percutaneously inserted 
into the nucleus pulposus. Laser energy is applied 
through the fiber, resulting in vaporization of nucleus 
pulposus contents (3). 
Improvement in discogenic pain with PLDD is 
based upon laser-induced evaporation of water 
within the disc; this results in a very slight decrease in 
disc size due to water loss. Because the intervertebral 
disc is essentially a closed hydraulic system, a small 
decrease in volume leads to a significantly larger de-
crease of intradiscal pressure; in vitro experiments 
confirm this (4,5). The short term decrease in pressure 
is due to evaporation of water content within the 
nucleus pulposus; long term effects are thought to be 
due to protein denaturation, which limits the ability of 
the nucleus to resorb additional water and reduces 
stiffness of the disc (3,6,7). This hypothetically results 
in a more even distribution of weight across the in-
tervertebral disc (8). 
Consistent with a lumbar location for the major-
ity of intervertebral disc herniations, most published 
studies have focused on the use of PLDD for the 
treatment of lumbar disc disease. Thoracic discogenic 
pain or herniation causing neural impingement is less 
common than that in the cervical or lumbar regions. 
Certain impact injuries, such as parachute landings, 
can result in thoracic disc damage. Invasive treatment 
of such injuries often involves a thoracotomy proce-
dure with either a discectomy or fusion implantation. 
Alt h o ugh  m a n y st udi es h av e b een  do n e o n  lum b a r 
and cervical PLDD procedures, few have been done 
on the thoracic region. In order to assess the efficacy 
and safety of PLDD for the treatment of thoracic disc 
disease, we performed a study of ten patients with 
thoracic discogenic pain who were unresponsive to 
conservative intervention. 
Methods 
We performed a prospective study of ten pa-
tients (8 male and 2 female) with an age range of 35-73 
years. All patients presented with mid-thoracic axial 
(n=7) or radicular (n=1) pain that failed to improve 
with conservative management, which included typ-
ical modalities such as physical therapy, pain medi-
cation, and epidural steroid injections. Physical ex-
amination revealed localized thoracic pain without 
recreation of symptoms with palpation. The pain was 
either centralized or radiating to one side. There was 
no facet tenderness present. All the patients had neg-
ative facet injections, to evaluate for the possibility of 
facet joint pain as the underlying cause. The patients 
had positive discograms that correlated to their pain; 
in the case of the individual with radicular symptoms, 
she had total relief of her pain with a thoracic nerve 
root block, confirming this as the source of her pain. 
All patients were diagnosed with thoracic discogenic 
pain based on MRI and provocative discogram re-
sults. Magnetic resonance imaging (MRI) findings 
that were considered abnormal included changes de-
scribed as irregular nuclear shape, reduced disc 
height, hypo-intense disc signal, annular tears, high 
intensity zones, endplate changes, and Modic changes 
(9,10,11).  
All patients underwent diagnostic injections to 
confirm the source of their pain; these injections in-
cluded either thoracic nerve root blocks for radicular 
symptoms and/or provocative discograms (12). The 
provocative discograms involved low-pressure injec-
tions of at least three disc levels and one of the levels 
was utilized as a control. Thoracic discography has 
been utilized as a controversial confirmatory test for 
discogenic pain for some time with debatable results 
(13,14). Studies show false positive results with dis-
cograms to be as high as 25% (13,15).  A recent sys-
tematic review reported the published evidence to be 
of low quality (16). The authors identified only two 
studies by the same authors for inclusion, each over 
10 years old. They recommended that other methods 
may be equally effective. Due to the lack of estab-
lished accuracy of discography, we required the 
combination of an abnormal MRI and a positive pro-
vocative discogram to diagnose intervertebral discs as 
the source of pain and to identify potential study par-
ticipants.  
It was felt that gross herniations producing sig-
nificant cord compression would be better treated 
with a laminotomy approach, and that not enough 
disc material would be removed to resolve the steno-
sis in such situations. Thus only patients with con-
tained disc protrusions were considered for PLDD 
and patients with gross herniation were removed 
from the study and sent for laminotomy or conven-
tional discectomy. 
Patients’ chosen for the procedure reported their 
thoracic pain using the Visual Analog Scale (VAS) 
pain scores at baseline. Posttreatment, patients were 
evaluated every six months via telephone call or di-
rect patient contact for at least 18 months. The patient 
was specifically asked to address the pain level of the 
thoracic spine region and not the body as a whole. 
This was done to eliminate patients with short-term 
improvement from introducing bias. A 
double-blinded study would have been preferable 
with a sham group but was not possible at our facility.  
The procedure begins with a properly prepped 
and draped patient in the prone position. All patients 




cedure. Cefofloxin was utilized unless there was an 
allergy, in which case ciprofloxin was used. Mild se-
dation was used during the procedure and the patient 
was able to converse with the surgeon in order to ex-
press any unusual pain. Sedation involved a combi-
nation of benzodiazepines and opiates. Fluoroscopy 
was utilized during the procedure for proper count of 
the thoracic vertebrae and to determine the entry site. 
The entry site was similar in position to a typical tho-
racic discogram and was approximately 3 inches lat-
eral to the midline of the spine. Caution was necessary 
due to the lung fields being close to the needle entry 
site, increasing the risk of pneumothorax. Once the 
entry site was determined, the skin and deeper tissues 
were anesthetized with a mixture of 0.25% bupiva-
caine and 1% lidocaine with epinephrine via a 
27-gauge needle. A 15 blade was used to create a stab 
incision of approximately ¼ inch. Through the inci-
sion, an 18-gauge, 3.5-inch spinal needle was inserted 
and the needle was guided into the middle of the disc 
using fluoroscopy. Positioning was confirmed via 
anterior and lateral x-ray views. Once properly 
placed, a direct firing holmium laser (diameter 0.5 
mm) at 20 watts and 10 repetitions per second 
(6030-10405 Joules, mean 7633) was utilized in short 
bursts to vaporize the inside of the disc. In most cases 
these burst were of ten second intervals; the patient 
usually complained of burning mid back pain which 
limited the time per lasing period. After the lasing 
periods, the disc was “cooled” with normal saline (at 
least 100 ml) mixed with cefazolin (unless there was 
an allergy). Saline irrigation was performed after, not 
simultaneously with, laser application due to the size 
of the diameter of the working environment and be-
cause a running irrigant would reduce the laser's ef-
fectiveness and thus increase operating times. Total 
lasing time was approximately 3 minutes, but varied 
from 80 seconds to 300 seconds. In most cases, the end 
point was when the pressure in the disc was reduced 
and injection of the normal saline occurred without 
any resistance. At this point the needle was removed 
and either the next disc was commenced or the pro-
cedure was finished. Closure involved a single ste-
ri-strip over the incision. No sutures were used. Te-
graderm and 2x2 gauze was placed over the wound.  
Results 
All ten patients tolerated the procedure well. 
There were no complications. Expected possible 
complications included those seen with thoracic dis-
cogram and laser usage such as infection or discitis, 
pneumothorax, nerve injury, and burn injuries (14). 
Each patient had a post procedural chest x-ray to rule 
out pneumothorax; no pneumothorax was seen. 
Length of follow-up ranged from 18 to 31 months 
(mean: 24.2 months). Patients were asked to assess 
their thoracic pain via a VAS score preoperatively and 
at final follow-up visit. Median VAS score pretreat-
ment was 8.5 (range: 5-10) and median VAS at final 
follow-up was 3.8 (range: 0-9). Six of ten patients’ 
scores improved by at least 6 points; one patient im-
proved by 1 point and three patients’ scores did not 
improve. No patients reported worsening of symp-
toms. Results are summarized in Table 1. No side ef-
fects were reported, and no adverse events occurred 
during the procedure.  
Table 1. Pre- and post-intervention Visual Analog Scale 
(VAS) pain scores.  
Age  Sex  Pre-VAS  Post-VAS Postoperative  pe-
riod at post-VAS 
score measurement 
61  M  10  9 31  months 
44  M  7  7 31  months 
73  F  8  8 29  months 
47  M  10  0* 26  months 
47  M  9  2* 25  months 
64  M  10  3* 25  months 
46  F  10  2* 20  months 
35  M  8  2* 19  months 
55  M  5  5 18  months 
49  M  8  0* 18  months 
M: Male 
F: Female 
Pre-VAS: Visual Analog Scale pain score prior to PLDD. 
Post-VAS: Visual Analog Scale pain score after PLDD. 
*Patients (n=6, 60%) experiencing at least 6 point improvement in 
VAS postoperatively. Note that remaining patients reported mi-
nimal or no improvement. 
 
Discussion 
Thoracic disc disease is much less common than 
that of lumbar and cervical discs. However, certain 
types of impact, such as parachute landing, carry an 
increased risk of thoracic disc injury. Optimal treat-
ment of thoracic discogenic pain is identical to that of 
disease of other spinal regions, i.e. aggressive medical 
management with anti-inflammatory medication, hot 
compresses, and physical therapy. Although epidural 
steroid injections are questionably proven to help 
with such cases, they are commonly utilized and are 
thus considered as a conservative therapy. Patients 
who fail to improve with conservative treatments 
have several invasive options, including conventional 
thoracotomy procedures for discectomy and fusion, 
posterior fusion, laminotomy, and disc decompres-
sion. These procedures generally carry significant risk 
and down time for potential patients. 
Several different types of lasers are used when 
performing PLDD. High energy laser carriers the risk 




cient to adequately induce vaporization (1). Lasers 
near the infrared region currently used in PLDD in-
clude neodymium:ytrium-aluminum garnet laser 
[Nd:YAG], holmium:ytrium- aluminum-garnet laser 
[Ho:YAG], and diode laser. Lasers with visible green 
radiation include double-frequency Nd:YAG laser 
and potassium-titanyl-phosphate [KTP] laser. Most 
lasers use a 3mm outer cannula combined with a fi-
beroptic viewing cable (17). There is no clear consen-
sus regarding the most effective and safe laser or the 
ideal wavelength that should be used (1). Most lasers 
provide 1200 Joules of energy in a pulsatile fashion 
(17). 
PLDD is a minimally invasive technique that 
reduces intradiscal pressure by vaporization of a 
small volume of water within the nucleus pulposus. 
This results in decreased overall pressure and a more 
even distribution of weight across the disc, with sub-
sequent relief of discogenic pain. PLDD is performed 
most commonly for lumbar disc disease, and pub-
lished reports on the efficacy of PLDD in thoracic 
discogenic pain are lacking. The majority of PLDD 
studies are of small size and observational in nature; 
thus the true efficacy of this technique is uncertain 
(18). Multiple case series have reported success with 
PLDD for the treatment of lumbar discogenic pain 
(15,19-30); however, no randomized controlled trials 
have been performed. A systematic review by Singh 
et al. reported that conclusive evidence of efficacy is 
lacking, and large scale, comparative trials are war-
ranted given the potential benefit of PLDD (18). The 
majority of authors report fair to good improvement 
in approximately 75% of patients, most commonly 
based upon the McNab scale. Immediate relief is re-
ported to occur in 75-90% of patients. Rates of com-
plication are low, the most common being septic or 
aseptic discitis, disc rupture, epidural hematoma, and 
nerve root damage (24,30-32).  
A recent study on thoracic PLDD procedures by 
Hellinger et al. reported improvement in 41 of 42 pa-
tients six weeks after percutaneous laser decompres-
sion and nucleotomy (PLDN) (35). The authors re-
ported three adverse events: one occurrence each of 
pneumothorax, pleurisy, and spondylodiscitis. 
Long-term outcome was not reported and thus it is 
unknown if their results extended beyond the study 
period of 6 weeks.  
In our study, six of ten patients reported signifi-
cant pain relief based on Visual Analog Scale pain 
scores concerning their thoracic pain issue. Utilizing a 
paired student’s t-test, the differences between the 
pre- and post-treatment groups showed greater than a 
99% confidence interval confirming that the im-
provement was indeed significant. The 60% im-
provement level noted is slightly lower, although still 
in agreement, with published reports of PLDD in pa-
tients with lumbar disc disease (15,19,34). Of interest, 
patients appeared to fall into two main groups: those 
gaining significant improvement and those receiving 
little or no improvement at all. In reviewing the pa-
tients who failed treatment, we could not distinguish 
any specific features, such as MRI findings or other 
clinical data, which could be utilized to screen these 
potential failed patients in the future.  
Importantly, no adverse events occurred in the 
intra- or postoperative period. Intervention for the 
treatment of thoracic disc disease carries a risk of 
pneumothorax, and particular concern was given to 
this possibility during the intervention. No patient 
developed pneumothorax, and no evidence of discitis, 
infection, or nerve injury was noted.  
Conclusion 
This is one of the first reports of the successful 
application of PLDD for the treatment of thoracic 
discogenic pain. Although the study group is small 
with only ten patients, six out of the ten patients re-
ported significant improvement at long-term (greater 
than 18 month) follow-up, and no adverse events 
were reported. PLDD could be considered a viable 
option with a low risk of complication for the treat-
ment of thoracic discogenic pain that does not resolve 
with conservative treatment. Nonetheless, due to the 
small study size, we recommend a larger 
double-blinded study to confirm our results.  
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